Compare Natera Inc. Common Stock (NTRA) vs Quanta Services Inc (PWR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Quanta Services Inc — how do they compare? Natera Inc. Common Stock trades at $392.78 (market cap $57.03B), while Quanta Services Inc trades at $651.21 (market cap $99.31B). The key difference: Quanta Services Inc is the larger of the two by market cap, and Quanta Services Inc pays a 0.07% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Quanta Services Inc for 62 Days on average.
| NTRA | PWR | |
|---|---|---|
Market Cap | $57.03B | $99.31B |
Volume | 1,131,157 | 1,067,966 |
Sector | Health | Industrials |
52-Week High | $425.64 | $785.24 |
52-Week Low | $179.42 | $412.21 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $56.18B | $105.40B |
Dividend Yield | — | 0.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
PWR trades at $688.88, down 0.85% on the day, with a bullish technical outlook supported by moving averages and a strong $53B backlog. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Revenue growth is robust, rising from $17.1B in 2022 to $28.5B in 2025, though valuation multiples like a P/E of 78.82 are elevated. Analyst sentiment is overwhelmingly positive, with 27 buy ratings and a consensus price target of $802.08, implying significant upside.
The outlook for PWR is favorable, driven by infrastructure demand and AI-related data center investments, but risks include high valuation sensitivity, execution challenges from rapid growth, and macroeconomic pressures on capital spending. The stock's near-term performance will hinge on Q3 earnings delivery and margin sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Quanta Services Inc
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two reportable segments: electric power infrastructure solutions and underground utility and infrastructure solutions. In October 2021, the company completed the acquisition of Blattner, a provider of comprehensive engineering, procurement, and construction solutions to customers in the renewable energy industry.
Read more on PWR →
